Literature DB >> 17887699

Structural NMR and ab initio study of salicylhydroxamic and p-hydroxybenzohydroxamic acids: evidence for an extended aggregation.

Begoña García1, Fernando Secco, Saturnino Ibeas, Asunción Muñoz, Francisco J Hoyuelos, José M Leal, María L Senent, Marcella Venturini.   

Abstract

The acid-base behavior and self-aggregation of salicylhydroxamic (SHA) and p-hydroxybenzohydroxamic acids (PHBHA)have been investigated by UV and 1HNMR spectroscopy, respectively. The acid-base parameters, measured in H2O at 25 degrees C and I=0.1 M, were pK1=7.56, pK2=9.85 for SHA and pK1=8.4, pK2=9.4 for PHBHA. The 1H NMR signals for salicylhydroxamic and p-hydroxybenzohydroxamic acids measured in acetone indicate that both acids self-aggregate according to a mechanism where two monomers produce planar E-E dimers stabilized by horizontal H-bonds. Further dimer aggregation yields sandwich-like tetramer structures stabilized by vertical H-bonds and pi-pi interactions. The p-hydroxybenzohydroxamic tetramers, less stable than those of salicylhydroxamic, contain two water molecules in their structures. The gas-phase structures of salicylhydroxamic acid and its anions were investigated by ab initio calculations using the density functional theory at the B3LYP/AUG-cc-pVDZ level. The SHA most stable gas-phase conformer is the A-Z amide, a structure with all three phenolate (OP), carboxylate (OC), and hydroxamate (OH) oxygen atoms in the cis position. The B-Z amide, with the OP oxygen trans to OC, lies 5.4 kcal above the A-Z amide. The most stable monoanion is the N-deprotonated A-Z amide.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17887699     DOI: 10.1021/jo0709798

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  1 in total

1.  Assembling ligands in situ using bioorthogonal boronate ester synthesis.

Authors:  Sung Bin Y Shin; Ramiro D Almeida; Guillermo Gerona-Navarro; Clay Bracken; Samie R Jaffrey
Journal:  Chem Biol       Date:  2010-11-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.